Ligand Pharmaceuticals Inc - Company Profile

Powered by

All the sales intelligence you need on Ligand Pharmaceuticals Inc in one solution.

  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how Ligand Pharmaceuticals Inc fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with Ligand Pharmaceuticals Inc.

Back to companies

Ligand Pharmaceuticals Inc: Executives

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

The following section provides information on Ligand Pharmaceuticals Inc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Ligand Pharmaceuticals Inc's management and employees, unlock the full data with our company analytics monitoring tool.

Executives

John W. Kozarich, PhD

Chairman Executive Board Since: 2007 Age: 75

Mr. John W. Kozarich has been the Chairman of the company since 2007. He served as a Director of the company since 2003. Currently, he is also serving as the Distinguished Scientist of ActivX Biosciences. Prior to this, he served as the Chairman, the Director and President of ActivX Biosciences.

Read Hide full bio of John W. Kozarich, PhD

Todd C. Davis

Chief Executive Officer; Director Executive Board Since: 2022 Age: 64

Mr. Todd C. Davis has been the Chief Executive Officer since 2022. He serves as member of the Board since March 2007. Prior to this, he served Founder and Managing Partner of HealthCare Royalty Partners from 2006 to 2018. Earlier to this, he worked as partner for Apax Partners.

Read Hide full bio of Todd C. Davis

Tavo Espinoza

Chief Financial Officer Senior Management Since: 2022 Age: 54

Mr. Tavo Espinoza has been the Chief Financial Officer of the company since 2022. Prior to this, he served as the Senior Vice President, Finance of the company. Previously, he served as the Senior Director, Finance at Receptos. Before that, he served as the Senior Director, Accounting at Illumina.

Read Hide full bio of Tavo Espinoza

Andrew Reardon

Chief Legal Officer Senior Management Since: 2022 Age: 50

Mr. Andrew Reardon has been the Chief Legal Officer of the company since 2022. Prior to this, he served as the Chief Legal Officer at HealthCare Royalty Management. Previously, he served as the Senior Associate at Willkie Farr & Gallagher.

Read Hide full bio of Andrew Reardon

James Pipkin, PhD

Vice President - New Product Development Senior Management
Gain a 360-degree view of Ligand Pharmaceuticals Inc and make more informed decisions for your business Gain a 360-degree view of Ligand Pharmaceuticals Inc and make more informed decisions for your business Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer